Why the study?
While epidemiological evidence supports the clinical benefits of exercise, understanding of the molecular mechanisms underlying its cardiac benefits remains incomplete, which is essential to identifying therapeutic targets.
Understanding the molecular mechanisms of exercise-induced cardiac benefits may identify novel therapeutic targets for heart failure.
May identify novel heart failure targets; hypothesis-generating and should not yet change practice.
Exercise exerts myriad cardiovascular benefits and protects against most forms of cardiovascular disease. While extensive epidemiological evidence supports the clinical benefits of exercise, our understanding of the molecular underpinnings of its benefits in the heart remains incomplete. Pinpointing these mechanisms is essential to identifying molecular targets modulated by exercise for therapeutic gain. In this review, we discuss the cellular and molecular mechanisms through which exercise benefits the heart, with a focus on the cardiomyocyte. We highlight cardiomyocyte-secreted mediators of intercell communication, intracellular signaling pathways, transcriptional regulation, and posttranscriptional mechanisms through noncoding RNAs that have been implicated in the cardiac exercise response. We emphasize pathways and mediators regulated by exercise training that may provide therapeutic targets in heart failure.
No takes yet. Share an insight, caveat, or question.
Khetarpal et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: